Product category:
Other analytical instruments
News Release from: MET | Subject: MOHLW biocompatibility testing
Edited by the Laboratorytalk Editorial
Team on 12 April 2006
Medical device testing to Japanese
requirements
Many medical device manufacturers are seeking to promote their products in Japan, a decision which can be very rewarding but poses its own challenges
While Japan accepts testing according to ISO 10993, there are some unique requirements in Japanese medical device regulations that may be more sensitive and challenging, with concepts being similar and methods being different To market a device in Japan, it is very likely that the Ministry of Health Labor and Welfare (MOHLW) will insist on testing conducted according to their specifications
This article was originally published on Laboratorytalk on 3 Oct 2003 at 8.00am (UK)
Related stories
Easier storage for steam biological indicators
Biological indicators for steam sterilisation, including spore strips, discs, dots and suspensions, can now be stored at or below 30C in a variety of environments
MET in partnership with Namsa now provide comprehensive testing to MOHLW biocompatibility testing protocols, including exaggerated extraction methods, colony assay cytotoxicity, MHLW sensitisation, MHLW irritation and MLHW geneotoxicity.
Japanese ministry regulations require testing and reporting to these specific protocols and Namsa have validated studies to allow testing to a wide variety of specific Japanese requirements.
Reports are compiled by native Japanese speakers, ensuring rapid progress through the regulatory system.
In addition, MET also has the capability to conduct tests according to Japanese Pharmacopoeia.
• MET: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
